Digital tests may offer a new way to track brain health in tumor patients

NCT ID NCT07710131

Not yet recruiting Knowledge-focused Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study explores whether self-administered digital cognitive tests can accurately measure thinking skills like attention, memory, and processing speed in people with primary central nervous system lymphoma or low-grade gliomas. Participants will complete both digital tests (on a computer or mobile device) and traditional paper-and-pencil tests at various time points, including at home. The goal is to see if the digital versions are a reliable and convenient alternative for monitoring cognitive function over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital cognitive assessment (TestMyBrain and Mobile Toolbox)
What this could lead to: If successful, this could provide a convenient, at-home method for monitoring cognitive health in brain tumor patients, reducing the need for in-clinic testing.
What could go wrong: This is a small pilot study, so results may not generalize. Digital tests may not capture all aspects of cognitive function as accurately as traditional methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm cognitive disorder Cognitive Dysfunction low grade glioma primary central nervous system lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMOR COGNITIVE DYSFUNCTION IDH MUTATION LOW GRADE GLIOMA PCNSL

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.